| Dr Elliott Jody Bilofsky, DO | |
|
202 Memorial Drive, Suite 1, Everett, PA 15537 | |
| (814) 623-6400 | |
| (814) 623-1963 |
| Full Name | Dr Elliott Jody Bilofsky |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 37 Years |
| Location | 202 Memorial Drive, Everett, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982662540 | NPI | - | NPPES |
| 0011621390006 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0905X | Otolaryngology - Otolaryngology/facial Plastic Surgery | OS006511L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Altoona | Altoona, PA | Hospital |
| Upmc Bedford Memorial | Everett, PA | Hospital |
| Penn Highlands Huntingdon | Huntingdon, PA | Hospital |
| Upmc Presbyterian Shadyside | Pittsburgh, PA | Hospital |
| Fulton County Medical Center | Mcconnellsburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upmc Altoona Regional Health Services, Inc. | 5395659312 | 214 |
News Archive
Lung cancer patients with diabetes tend to live longer than patients without diabetes, according to a Norwegian study published in the November issue of the Journal of Thoracic Oncology, the official publication of the International Association for the Study of Lung Cancer.
HeartSmarts, a faith-based community education and outreach program, is an effective method for teaching underserved communities about heart health in New York City, according to a study published in the Journal of Religion and Health.
Home Diagnostics, Inc., a leading developer, manufacturer, and marketer of blood glucose monitoring systems, today announced the results of a TRUE2go™ clinical performance study published in the October 2009 issue of the journal Diabetes Technology & Therapeutics. The study, "Clinical Performance of the TRUE2go Blood Glucose System – A Novel Integrated System for Meter and Strips," demonstrated the accuracy and precision of the TRUE2go system and found that it was both easy and convenient to use by patients.
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced it is working with Quest Diagnostics, the world's leading provider of diagnostic information services, to expand COVID-19 antibody testing to more than 20 Quest laboratories across the U.S.
For years I had tried and failed to understand why so many of my physician colleagues persisted in ordering tests, procedures, and treatments that seemed to provide no benefit to patients and even risked harming them.
› Verified 7 days ago
| Entity Name | Upmc Altoona Regional Health Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396724217 PECOS PAC ID: 5395659312 Enrollment ID: O20040312000257 |
News Archive
Lung cancer patients with diabetes tend to live longer than patients without diabetes, according to a Norwegian study published in the November issue of the Journal of Thoracic Oncology, the official publication of the International Association for the Study of Lung Cancer.
HeartSmarts, a faith-based community education and outreach program, is an effective method for teaching underserved communities about heart health in New York City, according to a study published in the Journal of Religion and Health.
Home Diagnostics, Inc., a leading developer, manufacturer, and marketer of blood glucose monitoring systems, today announced the results of a TRUE2go™ clinical performance study published in the October 2009 issue of the journal Diabetes Technology & Therapeutics. The study, "Clinical Performance of the TRUE2go Blood Glucose System – A Novel Integrated System for Meter and Strips," demonstrated the accuracy and precision of the TRUE2go system and found that it was both easy and convenient to use by patients.
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced it is working with Quest Diagnostics, the world's leading provider of diagnostic information services, to expand COVID-19 antibody testing to more than 20 Quest laboratories across the U.S.
For years I had tried and failed to understand why so many of my physician colleagues persisted in ordering tests, procedures, and treatments that seemed to provide no benefit to patients and even risked harming them.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elliott Jody Bilofsky, DO 202 Memorial Drive, Suite 1, Everett, PA 15537 Ph: (814) 623-6400 | Dr Elliott Jody Bilofsky, DO 202 Memorial Drive, Suite 1, Everett, PA 15537 Ph: (814) 623-6400 |
News Archive
Lung cancer patients with diabetes tend to live longer than patients without diabetes, according to a Norwegian study published in the November issue of the Journal of Thoracic Oncology, the official publication of the International Association for the Study of Lung Cancer.
HeartSmarts, a faith-based community education and outreach program, is an effective method for teaching underserved communities about heart health in New York City, according to a study published in the Journal of Religion and Health.
Home Diagnostics, Inc., a leading developer, manufacturer, and marketer of blood glucose monitoring systems, today announced the results of a TRUE2go™ clinical performance study published in the October 2009 issue of the journal Diabetes Technology & Therapeutics. The study, "Clinical Performance of the TRUE2go Blood Glucose System – A Novel Integrated System for Meter and Strips," demonstrated the accuracy and precision of the TRUE2go system and found that it was both easy and convenient to use by patients.
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced it is working with Quest Diagnostics, the world's leading provider of diagnostic information services, to expand COVID-19 antibody testing to more than 20 Quest laboratories across the U.S.
For years I had tried and failed to understand why so many of my physician colleagues persisted in ordering tests, procedures, and treatments that seemed to provide no benefit to patients and even risked harming them.
› Verified 7 days ago